........... If the Independent Data Monitoring committee said it...

........... If the Independent Data Monitoring committee said it would be unethical to prolong the ph2 trial, ie. Not allowing the chemo only patients to be deprived HerVaxx and the extension of life it brings alongside quality of life, the duration of response etc, what is a like minded FDA made up of similar experts going to recommend ???
Current 20c share price gives no credit to this implication, gives the chance of a Big Pharma deal a 50% probability at best, when blind Freddy can see its now a foregone conclusion............................

Hi there Unbelievable, agree yours appears to be a logical argument however is it possible the decision to cut the trial numbers (due the outstanding outcome) and therefore time required is based on or limited to that particular trial step - poor analogy - the cake mixture looks and tastes good but you have yet to put it in the oven to determine if it is a Royal show winner ? Suggest perhaps would be great if one for our experts in the field could explain further.